Steven H Rouhandeh's Net Worth

$209 Thousand

Estimate Recalculated Nov 1, 2024 04:26AM EST

Who is Steven H Rouhandeh?

Steven H Rouhandeh does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ACCESS PHARMACEUTICALS INC, ENHANCE BIOTECH INC, Somanta Pharmaceuticals Inc., MACROCHEM CORP, and BIOENVISION INC.

SEC CIK

Steven H Rouhandeh's CIK is 0001294343

Past Insider Trading and Trends

2020 was Steven H Rouhandeh's most active year for acquiring shares with 11 total transactions. Steven H Rouhandeh's most active month to acquire stocks was the month of April. 2020 was Steven H Rouhandeh's most active year for disposing of shares, totalling 8 transactions. Steven H Rouhandeh's most active month to dispose stocks was the month of October. 2015 saw Steven H Rouhandeh paying a total of $3,670,000.00 for 1,000,000 shares, this is the most they've acquired in one year. In 2020 Steven H Rouhandeh cashed out on 1,085,000 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

PLASMATECH BIOPHARMACEUTICALS INC (ABEO) Snapshot price: $5.55

Executive Chairman

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+7.80%
38.59K
—
—
533.59K
May 25
Form 4
-0.72%
-80.00K
$2.01
-$160,888.00
11.08M
Scheduled
May 3
Form 4
-0.71%
-80.00K
$2.23
-$178,624.00
11.16M
Scheduled
Mar 18
Form 4
-1.06%
-120.00K
$2.97
-$356,808.00
11.24M
Scheduled
Feb 16
Form 4
-2.07%
-240.00K
$3.01
-$722,832.00
11.36M
Scheduled
Feb 8
Form 4
-2.68%
-320.00K
$2.06
-$658,516.23
11.6M
Scheduled
Jan 14 - Jan 19
Form 4
—
0
—
—
0
Nov 20
Form 4
-0.02%
-1.99K
$2.00
-$3,981.38
11.92M
Scheduled
Sep 15
Form 4
-0.65%
-78.01K
$2.07
-$161,725.69
11.92M
Scheduled
Sep 10 - Sep 11
Form 4
-0.66%
-80.00K
$2.85
-$228,312.00
12M
Scheduled
Aug 17
Form 4
+32.00%
120K
—
—
495K
May 20
Form 4
—
0
—
—
0
Mar 16
Form 4
—
0
—
—
0
Apr 9
Form 4
—
0
—
—
0
Dec 14
Form 4
—
0
—
—
0
Dec 13
Form 4
—
0
—
—
0
Feb 11
Form 4/A
∞
375K
—
—
375K
May 11
Form 4
∞
375K
$7.34
$2,752,500.00
375K
May 11
Form 4/A
+19,535.85%
13.38M
$4.00
$53,500,096.00
13.44M
Dec 24
Form 4
+19,207.05%
13.38M
$4.00
$53,500,096.00
13.44M
Dec 24
Form 4
—
0
—
—
0
Mar 7
Form 4
—
0
—
—
0
Dec 19
Form 4
—
0
—
—
0
Oct 25
Form 4
+89.82%
1.64M
—
—
3.46M
Feb 26
Form 4/A
∞
901.58K
—
—
901.58K
Jan 4
Form 4
+116.29%
916.17K
—
—
1.7M
Feb 4
Form 4
—
0
—
—
0
Dec 18
Form 4
—
0
—
—
0
Feb 4
Form 4/A
—
0
—
—
0
Nov 10
Form 4
∞
822.14K
—
—
822.14K
Jan 4
Form 4
—
0
—
—
0
Nov 10
Form 4
—
0
—
—
0
Dec 6
Form 4
—
0
—
—
0
Oct 24
No matching records found

ENHANCE BIOTECH INC No price found

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

Somanta Pharmaceuticals Inc. No price found

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-8.25M
—
—
0
Jan 4
Form 4
—
0
—
—
0
Jan 31
Form 3
—
0
—
—
0
No matching records found

MACROCHEM CORP No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
23.42M
Dec 18
Form 4
—
0
—
—
0
Apr 18 - Jun 12
Form 4
+260.35%
17.88M
—
—
24.74M
Apr 25
Form 4
—
0
—
—
0
Apr 18
Form 4
+664.99%
6.83M
$0.60
$4,099,835.40
7.86M
Oct 10
Form 4
—
0
—
—
0
Mar 5
Form 4
—
0
—
—
0
Feb 13
Form 4
—
0
—
—
0
Dec 28
Form 3
—
0
—
—
0
No matching records found

BIOENVISION INC No price found

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+11.25%
688.33K
$1.50
$1,032,499.50
6.81M
May 1
Form 4
+24.00%
1.23M
$3.38
$4.43
6.35M
Nov 1
No matching records found